Company Overview
P3 Health Partners Inc. operates as a patient-centered and physician-led population health management company that delivers superior care services across the United States through a network of clinics and wellness centers. The enterprise functions within the Healthcare sector, specifically the Medical Care Facilities industry, positioning it to address the needs for accessible medical services and wellness management. The company maintains a market capitalization of $604.36M and generated annual revenue of $1.44B, while employing a workforce of 360 individuals. These financial figures indicate that the organization holds a substantial market presence, yet the negative growth trajectory suggests a challenging operational environment for this Henderson, Nevada-based entity founded in 2020. The scale of operations, defined by a market cap exceeding half a billion dollars, contrasts with the recent decline in revenue, highlighting the volatility inherent in the population health management landscape.
Financial Health
The company reported revenue of $1.44B over the trailing twelve months, accompanied by a net income of -$131,046,000 and an EBITDA of -$168,759,008. The significant disparity between the substantial revenue figure and the negative net income reveals a cost structure where operating expenses and losses severely erode profitability, resulting in a loss of over $131 million despite generating billions in sales. Free cash flow stands at -$51,895,376, which indicates that the company is consuming cash rather than generating it, thereby limiting its financial flexibility and ability to fund organic expansion without external capital. All three margins reflect negative performance: the gross margin is -4.0%, the operating margin is -12.8%, and the profit margin is -9.1%. These negative percentages indicate that the company is incurring losses at every stage of production and operation, with the operating margin loss being particularly severe relative to the gross margin. In terms of liquidity and leverage, the company holds cash of $37.71M against total debt of $264.96M, resulting in a debt-to-equity ratio of 1399.84. This balance sheet configuration is highly leveraged and aggressive, as the debt load far exceeds available cash reserves and equity. The current ratio is 0.32, a metric that indicates the company faces potential short-term liquidity challenges as current assets are insufficient to cover current liabilities. Furthermore, the Return on Equity is -202.6% and the Return on Assets is -20.9%, metrics that reveal management is currently destroying value rather than generating returns on the capital invested by shareholders and creditors.
Valuation Assessment
The valuation metrics present a complex picture, with a P/E Ratio (TTM) listed as N/A due to losses, while the Forward P/E is reported at -14.17. The negative forward P/E implies that the market expects continued negative earnings in the near future, preventing the use of traditional earnings-based valuation methods. The price-to-book ratio is -0.52, which indicates that the market values the company at a negative multiple of its book value, reflecting the extent of accumulated losses and potentially negative net asset positioning. Alternative valuation metrics further illustrate this distress, with a Price to Sales ratio of 0.42 and an EV/EBITDA of -1.63. These figures suggest that the company is valued based on revenue multiples rather than profitability, as the negative EV/EBITDA confirms that enterprise value exceeds debt by a minimal amount before accounting for the significant cash burn. The stock has a 52-Week High of $11.30 and a 52-Week Low of $1.52, placing the current trading range within a highly volatile band typical of distressed healthcare assets. The Beta is 0.85, indicating that the stock's price volatility is slightly lower than the broader market, suggesting it may be less sensitive to general market swings but remains subject to specific sector headwinds.
Growth & Income
Revenue growth year-over-year stands at -4.7%, while earnings growth is listed as N/A due to the absence of positive earnings. The absence of earnings growth combined with declining revenue suggests a contraction in the business model's effectiveness, as the company is unable to offset costs to maintain profitability even as it attempts to manage its population health portfolio. As a non-dividend payer, the company reports a Dividend Yield of N/A and a Payout Ratio of 0.0%. This structure implies that the company is not distributing cash to shareholders, likely due to the need to preserve remaining cash reserves to service its heavy debt load of $264.96M rather than funding income distributions. Consequently, the company reinvests its limited financial resources into maintaining its clinic and wellness center network rather than paying dividends to investors. The overall growth and income profile is characterized by negative revenue expansion, zero dividend returns, and a financial structure that prioritizes debt obligations over shareholder distributions, presenting a challenging environment for income-focused or growth-oriented investors.